Top Pharmaceutical Companies in Switzerland (2026 Update)
Browse Pharmaceutical companies in Switzerland with up-to-date profiles — funding rounds, investors, hiring, and expansion signals. Find recently funded and growing companies. Updated 2026.
Showing 152 Companies
| Company | Location | Founded | Industry | Services | Target Customers | Business Model | Revenue Model | Founders | Employees | Funding Stage | |
|---|---|---|---|---|---|---|---|---|---|---|---|
|
|
Ancora.ai
Ancora.ai is a patient-first, digital clinical trial na… |
Zurich, Switzerland
|
2017 |
AI
Big Data
+3
|
— | — | — | — | — | 9 | Grant |
|
Rocketvax AG
Implementing cutting-edge science in next-generation va… |
Basel, Switzerland
|
2020 |
Biotechnology
Health Care
+2
|
— | — | — | — | — | 6 | Grant |
|
flowbone SA
A New Generation of Injectable Biomaterials for a Quick… |
Lausanne, Switzerlan...
|
2020 |
Health Care
Health and Wellness
+4
|
— | — | — | — | — | 5 | Seed |
|
CHORD Therapeutics
Chord Therapeutics is dedicated to bringing new treatme… |
Geneva, Switzerland
|
2014 |
Biotechnology
Pharmaceutical
|
— | — | — | — | — | — | Series A |
|
Cube RM
Accelerate your Tendering Business with AI |
Zurich, Switzerland
|
2017 |
AI
IT
+4
|
— | — | — | — | — | 37 | Series A |
|
MetrioPharm
At the Forefront of Macrophage Metabolic Modulation |
Zurich, Switzerland
|
2007 |
Biotechnology
Health Care
+1
|
Development Of Self-regulating Immunomodulators
Clinical Trials For Rare And Common Inflammatory Diseases
+1
|
Patients With Inflammatory Diseases
Healthcare Providers Treating Rare Diseases
+2
|
— | — | — | 23 | Grant |
|
Noema Pharma
A clinical-stage biotech pioneering a portfolio of dise… |
Basel, Switzerland
|
2019 |
Biotechnology
Pharmaceutical
|
Development Of Oral Small Molecule Therapeutics
Advancement Of Clinical-stage Programs
+2
|
Patients With Neurological Disorders
Individuals Experiencing Menopause-related Symptoms
+2
|
B2B
B2D
|
Licensing
Product Sales
|
— | 33 | Series B |
|
|
Scantrust
Anti-counterfeiting, anti-diversion, product traceabili… |
Lausanne, Switzerlan...
|
2014 |
Big Data
IoT
+4
|
QR Code Management
Anti-counterfeiting Solutions
+3
|
Global Brands
Marketing Teams
+3
|
B2B
SaaS
+1
|
Subscription
Usage Based
+1
|
— | 41 | Grant |
|
Quercis Pharma
For a Healthier World |
Zug, Switzerland
|
2019 |
Biopharma
Biotechnology
+2
|
Research And Development Of Investigational Therapies
Partnership With Academic Institutions And Industry Leaders
+1
|
Patients In Need Of Lifesaving Medicines
Healthcare Providers
+2
|
B2B
B2C
+1
|
Product Sales
Licensing
+1
|
— | 8 | Private Equity |
|
Testmate Health
Testmate is pioneering the next generation of low-cost… |
Lausanne, Switzerlan...
|
2020 |
Biotechnology
Health Care
+3
|
Health Notifications
Patient Engagement Platform
+1
|
Health-conscious Individuals
Patients
+1
|
D2C
E Commerce
+1
|
Product Sales
One Time Purchase
|
— | 11 | Growth |
|
Pharvaris
Pioneering science for patient choice |
Zug, Switzerland
|
2015 |
Biotechnology
Health Care
+2
|
Development Of Oral Bradykinin B2 Receptor Antagonists
Research And Clinical Trials For Hereditary And Acquired Angioedema
+1
|
Patients With Hereditary Angioedema (HAE)
Patients With Acquired Angioedema Due To C1 Inhibitor Deficiency (AAE-C1INH)
+1
|
B2B
B2C
+1
|
Product Sales
Licensing
|
— | 139 | IPO |
|
|
Oculis
Oculis develops eye drops to treat ophthalmic diseases,… |
Lausanne, Switzerlan...
|
2017 |
Biotechnology
Health Care
+1
|
Development Of Ophthalmic And Neuro-ophthalmic Treatments
Innovative Pipeline And Clinical Trials
+1
|
Patients With Diabetic Macular Edema
Patients With Dry Eye Disease
+2
|
B2B
B2C
+1
|
Product Sales
Licensing
|
— | 75 | Post Ipo Equity |
|
Adaptyv
The cloud lab for protein designers |
Lausanne, Switzerlan...
|
2020 |
Biotechnology
Pharmaceutical
|
Protein Validation
Experimental Data Management
+3
|
Protein Design Teams
Biotech And Pharmaceutical Companies
+2
|
B2B
SaaS
+1
|
Usage Based
Service Fee
+1
|
— | 36 | Series A |
|
|
TOLREMO therapeutics
Stopping non-genetic cancer drug resistance as it emerg… |
Basel, Switzerland
|
2017 |
Biotechnology
Pharmaceutical
|
Novel Oncology Drug Development
Targeted Cancer Therapy
+2
|
Cancer Patients
Oncologists
+2
|
B2B
White Label
|
Licensing
Product Sales
+1
|
— | 14 | Series A |
|
Arvelle Therapeutics
A biopharmaceutical company committed to delivering gro… |
Basel, Switzerland
|
2019 |
Biotechnology
Pharmaceutical
|
Online Gaming Platform
Slot Games
|
Gaming Enthusiasts
Casual Online Gamers
+2
|
B2B
B2B2C
|
Product Sales
Licensing
|
— | 3 | Acquired |
|
ObsEva SA
ObsEva. Nature meets Nurture |
Plan-les-ouates, Swi...
|
2012 |
Biotechnology
Health and Wellness
+2
|
— | — | — | — | — | 9 | Post Ipo Debt |
|
EraCal Therapeutics
Towards an efficacious and well-tolerated appetite-supp… |
Basel, Switzerland
|
2018 |
Biotechnology
Health Care
+1
|
— | — | — | — | — | 6 | Seed |
|
|
Vandria SA
We develop first-in-class mitophagy inducers that rejuv… |
Lausanne, Switzerlan...
|
2021 |
Manufacturing
Pharmaceutical
|
— | — | — | — | — | 14 | Grant |
|
Basilea Pharmaceutica
For the benefit of patients |
Allschwil, Switzerla...
|
2000 |
Biotechnology
Pharmaceutical
|
— | — | — | — | — | 215 | Grant |
|
Versantis
Multiorgan support for rare pediatric and acute liver d… |
Zurich, Switzerland
|
2015 |
Health Care
Health and Wellness
+1
|
— | — | — | — | — | 2 | Grant |
Showing 20 of 152 companies in this list
